Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109617001000001110 | Poractant alfa 240mg/3ml endotracheopulmonary suspension vials (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109617101000001111 | Poractant alfa 240mg/3ml endotracheopulmonary suspension vials | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Poractant alfa 240mg/3ml endotracheopulmonary suspension vials | Is a | Product containing poractant alfa | false | Inferred relationship | Existential restriction modifier | ||
| Poractant alfa 240mg/3ml endotracheopulmonary suspension vials | Has active ingredient | Poractant alfa | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Poractant alfa 240mg/3ml endotracheopulmonary suspension vials 1 vial | Has VMP | False | Poractant alfa 240mg/3ml endotracheopulmonary suspension vials | Inferred relationship | Existential restriction modifier | |
| Curosurf 240mg/3ml endotracheopulmonary suspension vials (Trinity Pharmaceuticals Ltd) | Is a | False | Poractant alfa 240mg/3ml endotracheopulmonary suspension vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR